20-25458481-G-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_025176.6(NINL):āc.3745C>Gā(p.Gln1249Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000025 in 1,602,692 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_025176.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NINL | NM_025176.6 | c.3745C>G | p.Gln1249Glu | missense_variant | 22/24 | ENST00000278886.11 | NP_079452.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NINL | ENST00000278886.11 | c.3745C>G | p.Gln1249Glu | missense_variant | 22/24 | 1 | NM_025176.6 | ENSP00000278886.6 |
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 152184Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000794 AC: 19AN: 239278Hom.: 0 AF XY: 0.0000919 AC XY: 12AN XY: 130562
GnomAD4 exome AF: 0.0000248 AC: 36AN: 1450390Hom.: 0 Cov.: 32 AF XY: 0.0000305 AC XY: 22AN XY: 721956
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152302Hom.: 0 Cov.: 33 AF XY: 0.0000537 AC XY: 4AN XY: 74462
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 08, 2022 | The c.3745C>G (p.Q1249E) alteration is located in exon 22 (coding exon 21) of the NINL gene. This alteration results from a C to G substitution at nucleotide position 3745, causing the glutamine (Q) at amino acid position 1249 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at